NAPLEX CHRONIC KIDNEY DISEASE ACTUAL EXAM 2025 || 80
QUESTIONS ALREADY ANSWERED
1. Explain why it is necessary to evaluate and maintain iron stores before and
during treatment with erythropoiesis-stimulating agents (ESAs) in patients
with anemia of CKD.
Iron is not related to hemoglobin production.
Adequate iron stores are essential for effective erythropoiesis.
Iron supplementation is harmful in CKD patients.
ESAs do not require iron for their function.
2. A 50-year-old patient with end-stage renal disease is prescribed
cinacalcet along with several other medications. During a follow-up
appointment, the pharmacist identifies a potential interaction with a newly
prescribed antihypertensive medication. What should the pharmacist
recommend as the best course of action?
Continue all medications as prescribed.
Discontinue cinacalcet immediately.
Consult the prescribing physician about the interaction.
Switch to a different phosphate binder.
3. A 50-year-old woman with ESRD is scheduled to begin hemodialysis next
week. She has not received any vaccinations in the past. Which preventive
health measures should be prioritized for her before starting dialysis,
,considering her condition?
Only the influenza vaccine.
PCV13 and PCV23 vaccines, and the hepatitis B vaccine at twice
the standard dose.
Only the hepatitis B vaccine at standard dose.
PCV23 vaccine only.
,4. A patient with persistent high blood pressure and chronic kidney disease is
suspected to have activation of the RAAS. What medications can be used
to mitigate this activation?
Diuretics
Beta-blockers
Calcium channel blockers
Angiotensin-converting enzyme inhibitors (ACE inhibitors) or
angiotensin II receptor blockers (ARBs)
5. Which intravenous iron formulation is recommended for patients with
chronic kidney disease?
Iron sucrose
Sodium ferric gluconate complex
Ferumoxytol
Ferric carboxymaltose
6. During the patient's medication therapy management appointment, the
pharmacist performs a drug-drug interaction screening. In general, what
medication is noted to have multiple drug-drug interactions, especially
when administered by mouth?
Aspirin
Epoetin alfa
Iron dextran
Cinacalcet
, 7. What is the estimated glomerular filtration rate (GFR) range that
categorizes a patient as having Stage 3a chronic kidney disease (CKD)?
>90 mL/min/1.73 m2
60 to 89 mL/min/1.73 m2
QUESTIONS ALREADY ANSWERED
1. Explain why it is necessary to evaluate and maintain iron stores before and
during treatment with erythropoiesis-stimulating agents (ESAs) in patients
with anemia of CKD.
Iron is not related to hemoglobin production.
Adequate iron stores are essential for effective erythropoiesis.
Iron supplementation is harmful in CKD patients.
ESAs do not require iron for their function.
2. A 50-year-old patient with end-stage renal disease is prescribed
cinacalcet along with several other medications. During a follow-up
appointment, the pharmacist identifies a potential interaction with a newly
prescribed antihypertensive medication. What should the pharmacist
recommend as the best course of action?
Continue all medications as prescribed.
Discontinue cinacalcet immediately.
Consult the prescribing physician about the interaction.
Switch to a different phosphate binder.
3. A 50-year-old woman with ESRD is scheduled to begin hemodialysis next
week. She has not received any vaccinations in the past. Which preventive
health measures should be prioritized for her before starting dialysis,
,considering her condition?
Only the influenza vaccine.
PCV13 and PCV23 vaccines, and the hepatitis B vaccine at twice
the standard dose.
Only the hepatitis B vaccine at standard dose.
PCV23 vaccine only.
,4. A patient with persistent high blood pressure and chronic kidney disease is
suspected to have activation of the RAAS. What medications can be used
to mitigate this activation?
Diuretics
Beta-blockers
Calcium channel blockers
Angiotensin-converting enzyme inhibitors (ACE inhibitors) or
angiotensin II receptor blockers (ARBs)
5. Which intravenous iron formulation is recommended for patients with
chronic kidney disease?
Iron sucrose
Sodium ferric gluconate complex
Ferumoxytol
Ferric carboxymaltose
6. During the patient's medication therapy management appointment, the
pharmacist performs a drug-drug interaction screening. In general, what
medication is noted to have multiple drug-drug interactions, especially
when administered by mouth?
Aspirin
Epoetin alfa
Iron dextran
Cinacalcet
, 7. What is the estimated glomerular filtration rate (GFR) range that
categorizes a patient as having Stage 3a chronic kidney disease (CKD)?
>90 mL/min/1.73 m2
60 to 89 mL/min/1.73 m2
